Hycroft Announces Public Offering of Units
WINNEMUCCA, Nev., June 12, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or the "Company") is pleased to announce a proposed public underwritten offering of units of the Company (the "Units") for gross proceeds of...
Jin Jiang Hotels China Region Grants RJJ Hotels Sdn Bhd Licensing Rights to drive Cross-Border Hospitality Collaboration
New Hotel Management Agreement signed with Sanher Investment & Development Co. Ltd. to build the first Metropolo Hotel in Laos KUALA LUMPUR, Malaysia, May 29, 2025 /PRNewswire/ -- RJJ Hotels Sdn. Bhd (subsidiary of RIYAZ International Sdn....
Deutsche Bank Accelerates Digital Transformation with IBM's Software Portfolio
New license agreement gives Deutsche Bank increased access to IBM's innovative software solutions to accelerate innovation, optimize operations, and enhance customer experience FRANKFURT and EHNINGEN, Germany, May 27, 2025 /PRNewswire/ -- Deutsche...
Sonitus Medical and BHM Establish Strategic Cooperation
SHANGHAI, April 28, 2025 /PRNewswire/ -- Sonitus Medical has entered into a strategic cooperation with BHM, a renowned European manufacturer of bone conduction hearing devices. The two companies will engage in deep collaboration across product...
FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous EEG Monitor Approved in US
The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current electroencephalogram technologies The FDA has granted...
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
MELBOURNE, Australia, Feb. 26, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License...
NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer
SAN FRANCISCO and SUZHOU, China, Feb. 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
Frost & Sullivan grants Plataine the 2025 Technology Trailblazer Award for Agentic-AI for Manufacturing
Plataine's AI-Agents reduce cost and improve efficiency, productivity, performance, and ROI, enabling manufacturers to operate at scale with agility and environmental responsibility. SAN ANTONIO, Jan. 21, 2025 /PRNewswire/ -- Frost & Sullivan...
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform
Computational advancements enable earlier and more widespread use of antibody-antigen structural insights across drug discovery process These advancements have the potential to transform antibody discovery methods, broadening therapeutic...
FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections
SHANGHAI, Jan. 2, 2025 /PRNewswire/ -- Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx"，688373.SH) announced that MRX-5, its self-developed anti-infection drug, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug...